INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Historical Holders from Q1 2014 to Q3 2025

Symbol
IART on Nasdaq
CUSIP
457985208
Type / Class
Equity / Common Stock
Shares outstanding
77.6M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
72.9M
Holdings value
$1.04B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
204
Number of buys
94
Number of sells
-111
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 13.2% $137M 10.3M BlackRock, Inc. Jun 30, 2025
Rubric Capital Management LP 9.46% +57.5% $97.7M $36M 7.35M +58.4% Rubric Capital Management LP Jun 30, 2025
Invesco Ltd. 4.5% -16% $50M -$8.9M 3.49M -15.1% Invesco Ltd. Sep 30, 2025
MORGAN STANLEY 4.3% $44.9M 3.38M Morgan Stanley Jun 30, 2025

Institutional Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 72.9M $1.04B -$4.25M $14.33 204
2025 Q2 73.1M $897M -$36.9M $12.27 208
2025 Q1 73.5M $1.62B +$95.4M $21.99 217
2024 Q4 69.3M $1.57B +$40.7M $22.68 219
2024 Q3 68.3M $1.24B -$132M $18.17 219
2024 Q2 71M $2.07B +$131M $29.14 236
2024 Q1 65.3M $2.31B -$84.4M $35.45 273
2023 Q4 514K $22.4M +$883K $43.55 3
2023 Q3 67.5M $2.58B -$20.9M $38.19 255
2023 Q2 68.2M $2.8B -$206M $41.13 270
2023 Q1 72.1M $4.14B -$120M $57.41 271
2022 Q4 74M $4.15B +$368M $56.07 268
2022 Q3 70.5M $2.99B +$3.1M $42.36 257
2022 Q2 72.1M $3.9B -$64.7M $54.03 268
2022 Q1 74M $4.75B -$196M $64.26 263
2021 Q4 76.2M $5.11B +$22.6M $66.99 261
2021 Q3 76.9M $5.26B +$135M $68.48 251
2021 Q2 74.8M $5.1B +$62.4M $68.24 259
2021 Q1 73.3M $5.06B -$13.2M $69.09 252
2020 Q4 73.1M $4.75B +$106M $64.92 239
2020 Q3 72.7M $3.43B +$24.6M $47.22 227
2020 Q2 72.2M $3.39B +$37.8M $46.99 258
2020 Q1 71.4M $3.19B +$35.4M $44.67 246
2019 Q4 70.2M $4.09B +$76.1M $58.28 270
2019 Q3 68.6M $4.12B -$76.4M $60.07 269
2019 Q2 70.4M $3.93B +$25.7M $55.85 256
2019 Q1 70.9M $3.95B -$17.4M $55.72 252
2018 Q4 70.6M $3.18B -$136M $45.10 237
2018 Q3 73.2M $4.82B +$97.8M $65.87 239
2018 Q2 72.1M $4.64B +$178M $64.41 252
2018 Q1 70.1M $3.87B -$42.3M $55.34 232
2017 Q4 71.4M $3.42B +$94.6M $47.86 216
2017 Q3 68.3M $3.45B +$126M $50.48 210
2017 Q2 65.6M $3.58B +$87M $54.51 218
2017 Q1 67.3M $2.83B +$1.5B $42.13 231
2016 Q4 33.9M $2.91B +$121M $85.79 207
2016 Q3 32.8M $2.7B +$59.6M $82.55 228
2016 Q2 33.4M $2.67B +$55.4M $79.78 205
2016 Q1 32.8M $2.21B +$102M $67.36 190
2015 Q4 31.3M $2.12B +$35.2M $67.78 179
2015 Q3 30.9M $1.84B +$218M $59.55 185
2015 Q2 26.8M $1.81B -$23.3M $67.37 184
2015 Q1 27.6M $1.7B +$73.5M $61.65 168
2014 Q4 26.4M $1.43B +$6.33M $54.23 156
2014 Q3 26.3M $1.3B +$5.5M $49.64 139
2014 Q2 26.2M $1.23B +$22.1M $47.06 142
2014 Q1 24.9M $1.15B +$14M $45.99 137